Novartis Boxes In Roche, Ups Ownership Stake To “Blocking Minority”
Executive Summary
Novartis is upping the pressure on Roche to negotiate a merger agreement - or face the threat of a veto by its Swiss neighbor on any strategic moves it undertakes
You may also be interested in...
Novartis Resumes Merger Search; Talks Up Schering, Ups Stake In Roche
Novartis is resuming its search for a merger partner, CEO Daniel Vasella indicated during the company's 2003 results conference Jan. 22 in Zurich
Novartis Resumes Merger Search; Talks Up Schering, Ups Stake In Roche
Novartis is resuming its search for a merger partner, CEO Daniel Vasella indicated during the company's 2003 results conference Jan. 22 in Zurich
Idenix/Novartis Telbivudine NDA Filing Slated For Late 2005, IPO Says
Idenix plans to file an NDA for the hepatitis B therapy telbivudine in late 2005, the Cambridge-based biotech company says in an initial public offering filed with the Securities & Exchange Commission Dec. 15